A detailed history of Franklin Resources Inc transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 60,780 shares of CDMO stock, worth $751,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,780
Previous 60,780 -0.0%
Holding current value
$751,240
Previous $691,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.7 - $12.45 $41,935 - $77,924
6,259 Added 11.48%
60,780 $691,000
Q2 2024

Aug 14, 2024

BUY
$6.34 - $9.28 $28,162 - $41,221
4,442 Added 8.87%
54,521 $389,000
Q1 2024

May 13, 2024

SELL
$5.86 - $8.79 $44,330 - $66,496
-7,565 Reduced 13.12%
50,079 $335,000
Q4 2023

Feb 09, 2024

BUY
$4.64 - $9.56 $56,598 - $116,612
12,198 Added 26.84%
57,644 $374,000
Q3 2023

Nov 13, 2023

SELL
$9.4 - $14.04 $17,709 - $26,451
-1,884 Reduced 3.98%
45,446 $429,000
Q2 2023

Aug 11, 2023

BUY
$12.96 - $20.93 $400,632 - $647,009
30,913 Added 188.3%
47,330 $661,000
Q1 2023

May 12, 2023

BUY
$13.48 - $18.79 $431 - $601
32 Added 0.2%
16,417 $307,000
Q4 2022

Feb 10, 2023

SELL
$12.61 - $18.74 $252 - $374
-20 Reduced 0.12%
16,385 $225,000
Q3 2022

Nov 14, 2022

BUY
$15.33 - $20.36 $65,183 - $86,570
4,252 Added 34.99%
16,405 $313,000
Q2 2022

Aug 11, 2022

SELL
$11.63 - $21.55 $13,386 - $24,804
-1,151 Reduced 8.65%
12,153 $185,000
Q1 2022

May 13, 2022

SELL
$16.63 - $27.73 $7.14 Million - $11.9 Million
-429,044 Reduced 96.99%
13,304 $271,000
Q4 2021

Feb 11, 2022

BUY
$20.7 - $34.18 $9.16 Million - $15.1 Million
442,348 New
442,348 $12.9 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $768M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.